1. Introduction {#sec1-molecules-21-00601}
===============

Neuroblastoma is a tumor of neural progenitor cells, which widely metastasizes to skin, bone marrow, liver, and non-contiguous lymph nodes, and then becomes the most common extracranial solid tumor in children \[[@B1-molecules-21-00601]\]. Neuroblastoma is found in a greater than 7% of malignancies and near 15% of oncology deaths in children \[[@B2-molecules-21-00601]\]. The infant patients with metastasis only to skin, bone marrow, and liver have the good prognosis post treatment with the current anticancer drugs. The 5-year event-free survival rate of children with disseminated neuroblastoma (Stage 4) is still less than 40% post-treatment \[[@B3-molecules-21-00601],[@B4-molecules-21-00601]\]. In addition, neuroblastoma has resistance to chemotherapeutic drugs, and even recurrence \[[@B2-molecules-21-00601]\]. Therefore, the development of novel anti-neuroblastoma agents is still recommended to improve the patient outcomes.

Apoptotic inducers have been widely regarded as potential anti-cancer therapeutics and evaluated in pre-clinical or clinical trials \[[@B5-molecules-21-00601]\]. Apoptosis results from initiating Fas receptor-mediated or mitochondria-dependent pathways, subsequently converting DNA fragmentation, cytoskeletal protein degradation, and apoptotic body formation \[[@B6-molecules-21-00601]\]. Anti- and pro-apoptotic molecules included Bcl-2, BclXL, Bax, Bak, BAD, BIM, and BclXS, regulate in mitochondria-dependent apoptotic pathways \[[@B6-molecules-21-00601]\]. Tumor suppressor protein p53 with proapoptotic activity is the key transcription factor for up-regulation of pro-apoptotic genes like PUMA and Noxa.

γ-Bisabolene shows *in vitro* and *in vivo* antiproliferative and apoptotic activities against human oral squamous cell carcinoma \[[@B7-molecules-21-00601]\]. γ-Bisabolene induces the apoptosis of oral squamous cell carcinoma via p53-medaited signaling pathways. This study further investigates the antiproliferative and apoptotic mechanisms of γ-bisabolene against human neuroblastoma.

2. Results {#sec2-molecules-21-00601}
==========

2.1. Growth Inhibition and Apoptosis Induction of γ-Bisabolene to Human Neuroblastoma {#sec2dot1-molecules-21-00601}
-------------------------------------------------------------------------------------

To examine the growth inhibitory ability of γ-bisabolene, the survival rates of human neuroblastoma TE671 cells were examined using MTT assays 2 days post-treatment ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}B). γ-Bisabolene inhibited the growth of TE671 cells in a concentration-dependent manner, exhibiting a CC~50~ value of 8.2 μM ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}B).

Meanwhile, cell cycle analysis of flow cytometry with PI staining showed the increase in the sub-G1 fractions and the decrease in the G1 fractions of γ-bisabolene-treated cells compared to mock controls in a time-dependent manner ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}C,D). The results indicated anti-proliferative activity of γ-bisabolene to human neuroblastoma cells.

2.2. Apoptosis of Neuroblastoma Cells Induced by γ-Bisabolene {#sec2dot2-molecules-21-00601}
-------------------------------------------------------------

To test whether γ-bisabolene induces apoptosis of human neuroblastoma cells, the fractions of early (annexin-V positive/PI negative) and late (annexin-V positive/PI positive) apoptosis in treated were determined by flow cytometer with annexin V-FITC and PI staining ([Figure 2](#molecules-21-00601-f002){ref-type="fig"}A--C). γ-Bisabolene triggered the significant increase of early and late apoptosis on TE671 cells in dose-dependent manners. To further examine the mRNA and protein levels of caspases 3, 8 and 9 in treated cells, TE671 cells treated were harvested 48 h post treatment for total RNA extraction and the lysate preparation. Quantitative RT-PCR revealed that γ-bisabolene significantly induced the mRNA expression of caspases 3, 8, and 9 in dose-dependent manners ([Figure 3](#molecules-21-00601-f003){ref-type="fig"}A). Caspases 3, 8 and 9 were activated to greater than 5 folds in response to 10 µM γ-bisabolene. Subsequently, western blots indicated the dose-dependent increase in pro- and active forms of caspases 3, 8, and 9 in γ-bisabolene-treated cells 48 h post treatment ([Figure 3](#molecules-21-00601-f003){ref-type="fig"}B--E). Active forms of caspases 3, 8, and 9 exhibited 3.5-, 1.6-, and 2.3-fold increases post-treatment with 10 µM γ-bisabolene, respectively. The results demonstrated γ-bisabolene induces extrinsic and intrinsic apoptosis of human neuroblastoma.

2.3. ROS Production Increase and Mitochondrial Membrane Potential Decrease in Treated Cells {#sec2dot3-molecules-21-00601}
-------------------------------------------------------------------------------------------

To examine the apoptotic pathways of γ-bisabolene-induced apoptosis, the changes in the intracellular reactive oxygen species (ROS) levels and mitochondrial membrane potential (MMP) in γ-bisabolene-treated cancer cells was subsequently surveyed using flow cytometry analysis with DCFH-DA and DiOC6(3) staining, respectively ([Figure 4](#molecules-21-00601-f004){ref-type="fig"} and [Figure 5](#molecules-21-00601-f005){ref-type="fig"}). γ-Bisabolene treatment induced ROS production in human neuroblastom cells in a dose-dependent manner ([Figure 4](#molecules-21-00601-f004){ref-type="fig"}).

Quantitative analysis of MMP changes using DiOC6(3) staining demonstrated that γ-bisabolene significantly decreased the MMP of human neuroblastom cells ([Figure 5](#molecules-21-00601-f005){ref-type="fig"}A,B); a 97% decrease in MMP was found in TE671 cells treated with 5 μM of γ-bisabolene ([Figure 5](#molecules-21-00601-f005){ref-type="fig"}B). Therefore, the results indicated γ-bisabolene induces ROS production and injures the mitochondria in apoptosis of human neuroblastom cells.

2.4. The Increase of p53-Mediated Transcription in γ-Bisabolene-Treated Cells {#sec2dot4-molecules-21-00601}
-----------------------------------------------------------------------------

To examine the γ-bisabolene-induced apoptotic pathways of human neuroblastom cells, p53-mediated transcriptional activities for apoptosis induction were subsequently analyzed ([Figure 6](#molecules-21-00601-f006){ref-type="fig"}). Western blotting showed γ-bisabolene elevating the phosphorylation of p53 and p21 in TE671 cells ([Figure 6](#molecules-21-00601-f006){ref-type="fig"}A,B), linked with activation of PUMA and Bim expression, but not Noxa, in dose-dependent manners quantified using real-time RT-PCR ([Figure 6](#molecules-21-00601-f006){ref-type="fig"}C). Since down-regulation of casein kinase 2α (CK2α) was associated with activation of p53 transcriptional activities in apoptosis of γ-bisabolene-treated oral cancer cells \[[@B7-molecules-21-00601]\], the CK2α and CK2β expression in γ-bisabolene-treated neuroblastom cells was further characterized ([Figure 7](#molecules-21-00601-f007){ref-type="fig"}A--C). Real-time RT-PCR and western blotting demonstrated that γ-bisabolene significantly reduced the CK2α and CK2β expression in treated human neuroblastom cells. Therefore, CK2 down-regulation was suggested to be associated with p53-mediated apoptosis of γ-bisabolene-treated neuroblastom cells.

3. Discussion {#sec3-molecules-21-00601}
=============

Essential oils containing γ-bisabolene have demonstrated anti-proliferative activities to human oral cancer, prostate cancer, glioblastoma, lung carcinoma, breast carcinoma, and colon adenocarcinoma cell lines \[[@B7-molecules-21-00601],[@B8-molecules-21-00601],[@B9-molecules-21-00601],[@B10-molecules-21-00601]\]. The study first reports the potent antiproliferative and apoptotic activities of γ-bisabolene on human neuroblastom cells ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}, [Figure 2](#molecules-21-00601-f002){ref-type="fig"} and [Figure 3](#molecules-21-00601-f003){ref-type="fig"}). γ-Bisabolene induced apoptosis of human neuroblastom cells through increasing intracellular ROS, declining MMP, and activating p53-mediated transcriptional activities ([Figure 4](#molecules-21-00601-f004){ref-type="fig"}, [Figure 5](#molecules-21-00601-f005){ref-type="fig"}, [Figure 6](#molecules-21-00601-f006){ref-type="fig"} and [Figure 7](#molecules-21-00601-f007){ref-type="fig"}). MTT assays indicated γ-bisabolene at high concentrations (15 to 200 µM) was less cytotoxic than low concentrations (0.1 to 10 µM) ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}B), but cell cycle analysis demonstrated sub-G1 fraction as near 90% in treated cells with 20 µM 48 h post treatment ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}C,D). Since the MTT assay relies on mitochondrial dehydrogenase activity, γ-bisabolene at low concentrations (0.1 to 10 µM) was effective at triggering the mitochondria-dependent apoptosis of human neuroblastom cells, as consistent with the findings in [Figure 2](#molecules-21-00601-f002){ref-type="fig"}, [Figure 3](#molecules-21-00601-f003){ref-type="fig"}, [Figure 4](#molecules-21-00601-f004){ref-type="fig"}, [Figure 5](#molecules-21-00601-f005){ref-type="fig"}, [Figure 6](#molecules-21-00601-f006){ref-type="fig"} and [Figure 7](#molecules-21-00601-f007){ref-type="fig"}.

Tumor suppressor p53 has demonstrated its involvement in the mitochondrial apoptotic pathway, exerting transcriptional activities on regulating the expression of pro-apoptotic genes: e.g., PUMA, Bim, and NOXA \[[@B6-molecules-21-00601],[@B11-molecules-21-00601],[@B12-molecules-21-00601]\]. γ-Bisabolene concentration-dependently increased p53 phosphorylation that linked with up-regulation of p53 transcriptional activities on apoptotic genes PUMA and Bim in human neuroblastom cells ([Figure 6](#molecules-21-00601-f006){ref-type="fig"}). Since PUMA and Bim have been known as the activator for Bax involved in mitochondria-mediated apoptosis \[[@B13-molecules-21-00601]\], γ-Bisabolene-induced p53-mediated PUMA and Bim up-regulation correlated with the MMP decreases in treated neuroblastom cells ([Figure 5](#molecules-21-00601-f005){ref-type="fig"}). In addition, p53 could induce the Fas up-regulation that activates the extrinsic apoptotic pathway \[[@B14-molecules-21-00601]\]. Thus, p53 activation induced by γ-bisabolene might be responsible for increasing the expression and activity of caspase 8 ([Figure 3](#molecules-21-00601-f003){ref-type="fig"}). Results demonstrated γ-bisabolene triggering p53-mediated apoptosis of human neuroblastom cells.

Protein kinase CK2α participates in heart and neural tube development, maintains cell viability, and regulates cell cycle stages \[[@B15-molecules-21-00601],[@B16-molecules-21-00601],[@B17-molecules-21-00601],[@B18-molecules-21-00601]\]. CK2α has been identified to overexpress in human colorectal cancer \[[@B19-molecules-21-00601]\]; gene silence of CK2α small interfering RNA was associated with elevating the expression of p53/p21 and decreasing the expression of C-myc \[[@B20-molecules-21-00601]\]. Therefore, suppression of CK2α was suggested to a novel therapeutic approach for human colorectal cancer. This study demonstrated γ-bisabolene down-regulating the CK2α and CK2β expression in human neuroblastom cells ([Figure 7](#molecules-21-00601-f007){ref-type="fig"}A--C). Thus, down-regulation of CK2 was proposed to as one of promising mechanisms for activating p53-mediated apoptosis of human neuroblastom cells treated with γ-bisabolene ([Figure 7](#molecules-21-00601-f007){ref-type="fig"}D).

4. Materials and Methods {#sec4-molecules-21-00601}
========================

4.1. Cell Cultures {#sec4dot1-molecules-21-00601}
------------------

Human neuroblastoma TE671 cells were cultured in MEM medium (HyClone Laboratories, South Logan, UT, USA) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM glutamine and 1 mM sodium pyruvate at 37 °C in a humidified atmosphere of 5% CO~2~.

4.2. In Vitro Cytotoxicity Test {#sec4dot2-molecules-21-00601}
-------------------------------

Cytotoxic activity of γ-bisabolene (4-(1,5-dimethyl-4-hexenylidene)-1-methylcyclohexene) ([Figure 1](#molecules-21-00601-f001){ref-type="fig"}A) was assessed by MTT assay. Cells (5 × 10^4^ cells/mL) plated in 96-well plates overnight and then treated with indicated concentrations (0.1, 1, 5, 10, 15, 20, 50, 100, and 200 μM) for 48 h at 37 °C in humidified atmosphere of 5% CO~2~. Cell were incubated with 10 μL of a MTT solution for 4 h, reacted with 100 μL of stop solution for dissolving formazan crystals, and then measured with micro-ELISA reader by optical density (OD) at 570--630 nm. 50% cytotoxic concentration (CC~50~) of γ-bisabolene on TE671 cells was determined using the ID~50~ software developed by Dr. John Spouge with the survival rate of treated cells to mock cells.

4.3. Apoptosis and Cell Cycle Assay by Flow Cytometry {#sec4dot3-molecules-21-00601}
-----------------------------------------------------

Cells were treated with γ-bisabolene at 10 μM for 24 and 48 h, and harvested for cell cycle analysis by propidium iodide (PI) staining, and apoptosis assays with γ-bisabolene at 1, 5, 10, and 20 μM for 48 h by Annexin V-FITC apoptosis Detection Kit with PI (BioVision, Milpitas, CA, USA). Cell cycle and apoptosis assays were performed as described in our prior report \[[@B7-molecules-21-00601]\].

4.4. Mitochondrial Membrane Potential (MMP) Detection Assays {#sec4dot4-molecules-21-00601}
------------------------------------------------------------

Cells were treated with γ-bisabolene at 1, 5, 10, and 20 μM for 48 h; MMP changes were quantitated using flow cytometry with DiOC6(3) staining (Calbiochem, San Diego, CA, USA). Cells were stained with the DiOC6(3) solution at 37 °C in the dark for 1 h, and then measured using a flow cytometer with an excitation wavelength of 488 nm and an emission wavelength of 530 nm.

4.5. Detecting Intracellular Reactive Oxygen Species (ROS) by Flow Cytometry {#sec4dot5-molecules-21-00601}
----------------------------------------------------------------------------

Cells were treated with γ-bisabolene at 1, 5, 10, and 20 μM for 48 h, harvested, and then stained with 10 μM 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA, Sigma, Saint Louis, MO, USA) at 37 °C for 30 min in darkroom. DCF fluorescence converted from DCFH-DA by ROS was detected by flow cytometry with excitation wavelength of 485 nm and emission wavelength of 530 nm, as described in our prior report \[[@B21-molecules-21-00601]\].

4.6. Western Blot {#sec4dot6-molecules-21-00601}
-----------------

TE671 cells were treated with γ-bisabolene at 1, 5 and 10 μM for 48 h, collected, and lysed in the RIPA lysis buffer (Roche Diagnostics, New York, NY, USA). Lysates in sample buffer were boiled for 8 min, separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and then followed by western blotting assays, as described in our prior report \[[@B7-molecules-21-00601],[@B22-molecules-21-00601]\]. The blots were probed with specific primary antibodies against caspase 3 (Calbiocem), capspase 8, caspase 9 (upstate), phospho-p53(S15), p21 (Millipore, Billerica, MA, USA), phospho-p21(T145) (ABGENT, San Diego, CA, USA), casein kinase 2α (CK2α), and β-actin (Cell Signalling, Danvers, MA, USA), and then reacted with HRP-conjugated anti-mouse or anti-rabbit IgG antibodies (Invitrogen, Carlsbad, CA, USA). Immunoreactive bands were reacted with chemiluminescent western blotting detection reagents, and then pictured by autoradiography.

4.7. Real-Time RT-PCR {#sec4dot7-molecules-21-00601}
---------------------

Total RNA was extracted from mock control and treated cells with γ-bisabolene using the RNA purification kit (Invitrogen), and then converted into cDNA with oligo dT primer and SuperScript III reverse transcriptase (Thermo Fisher, San Jose, CA, USA). Two-step RT-PCR was performed using SYBR Green I, as described in our prior report \[[@B23-molecules-21-00601]\]. Oligonucleotide primer pairs in our study were listed as the following: (1) forward primer 5′-CAGTGGAGGCCGACTTCTTG-3′ and reverse primer 5′-TGGCACAAAGCGACTGGAT-3′ for human caspase 3; (2) forward primer 5′-TGTCCTACTCTACTTTCCCAGGTTTT-3′ and reverse primer 5′-GTGAGCCCACTGCTCAAAGAT-3′ for human caspase 9; (3) forward primer 5′-AGTGGGTATTTCTCTTTTGACACAG-3′ and reverse primer 5′-GTCTCCAATACGCCGCAACT-3′ for human Bim; (4) forward primer 5′-GACGACCTCAACGCACAGTA-3′ and reverse primer 5′-CACCTAATTGGGCTCCATCT-3′ for human PUMA; (5) forward primer 5′-GAGATGCCTGGGAAGAAGG-3′ and reverse primer 5′-TTCTGCCGGAAGTT CAGTTT-3′ for human Noxa; (6) forward primer 5′-GGATGGCCACTGTGAATAACTG-3′ and reverse primer 5′-TCGAGGACATCGCTCTCTCA-3′ for caspase 8; (7) forward primer 5′-GAACGCTTTGTCCACAGTGA-3′ and reverse primer 5′-TATCGCAGCAGTTTGTCCAG-3′ for human protein kinase CK2α; (8) forward primer 5′-CCCATTGGCCTTTCAGACAT-3′ and reverse primer 5′-CCGTGTGATGGTGTCTTGATG-3′ for CK2β; and (9) forward primer 5′-CCACCCATGGCAAATTCC-3′ and reverse primer 5′-TGGGATTTCCATTGATGACAAG-3′ for human GAPDH. Real-time PCR reaction mixture contained 2 μL of cDNA (reverse transcription mixture), 200 nM of each primer pair in SYBR Green I master mix (LightCycler TaqMAn Master, Roche Diagnostics). Relative mRNA levels of indicated genes were gene normalized by housekeeping gene GAPDH.

4.8. Statistical Analysis {#sec4dot8-molecules-21-00601}
-------------------------

All data from three independent experiments were used for measuring mean ± standard error (mean ± S.E.) that was compared using Student's *t*-test. *p* \< 0.05 was considered as statistically significant.

5. Conclusions {#sec5-molecules-21-00601}
==============

This study demonstrated that γ-bisabolene has potential to inhibit the growth and inducing apoptosis of human neuroblastom cells. γ-Bisabolene reduced the CK2α expression and activated p53-mediated mitochondrial apoptosis pathway in human neuroblastom cell. The results suggested γ-bisabolene as a potential agent of anti-proliferative and apoptosis-inducing activities for treating human neuroblastom cells.
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![Survival rates and cell cycle analysis of human neuroblastom cells in response to γ-bisabolene. The structure of γ-bisabolene ((*Z*)-1-Methyl-4-(6-methylhept-5-en-2-ylidene) cyclohex-1-ene) was shown (**A**). For antiproliferative assay (**B**), TE671 cells were grown in the indicated concentrations of γ-bisabolene for 48 h. Survival rate was calculated based on MTT assays; For cell cycle analysis (**C**), treated cells with 20 µM γ-bisabolene were fixed by 70% ethanol, incubated with PI solution, then examined using flow cytometry; The percentage of cell distribution was represented (**D**). \*\*\*, *p* value \< 0.001 compared with untreated cells.](molecules-21-00601-g001){#molecules-21-00601-f001}

![Apoptosis analysis of human neuroblastom cells in responses to γ-bisabolene. Cells were harvested 48 h post treatment, stained by Annexin V-FITC/PI dye, and then analyzed using flow cytometry (**A**); Annexin V positive/PI negative indicated early phase of apoptosis (**B**); Annexin V positive/PI positive presented as late apoptosis (**C**). \*\*\*, *p* value \< 0.001 compared with untreated cells.](molecules-21-00601-g002){#molecules-21-00601-f002}

![Relative mRNA and protein levels of caspases-3, 8, and 9 in γ-bisabolene-treated cells. Cells were harvested for total RNA extraction and western blotting 48 h post treatment. The relative gene expression was normalized to GAPDH in real-time PCR assays (**A**); Active forms of caspases 3, 8 and 9 in TE671 were characterized using western blotting (**B**); Relative band intensity of indicated caspase or active caspase was normalized by β actin, compared to the mock cells, and quantified using image J based on triplicate replicates of each experiment (**C**--**E**). \*\*, *p* value \< 0.01; \*\*\*, *p* value \< 0.001 compared with untreated cells.](molecules-21-00601-g003){#molecules-21-00601-f003}

###### 

Increase of intracellular ROS production in γ-bisabolene-treated cells. Cells were treated with γ-bisabolene for 48 h, harvested stained using DCF-DA, and then analyzed by flow cytometry with excitation and emission spectra of 495 nm and 529 nm respectively (**A**); Relative fluorescent intensity of DCF was further calculated (**B**). \*\*\*, *p* value \< 0.001 compared with untreated cells.

![](molecules-21-00601-g004a)

![](molecules-21-00601-g004b)

![Loss of mitochondrial membrane potential (ΔΨM) in human neuroblastom cells treated with γ-bisabolene. TE671 cells were stained using DiOC6(3), and then measured by flow cytometry (**A**); Relative changes in low MMP of cells treated with γ-bisabolene were shown (**B**). \*\*\*, *p* value \< 0.001 compared with untreated cells.](molecules-21-00601-g005){#molecules-21-00601-f005}

![Activation of p53 mediated transcriptional activity by γ-bisabolene. Western blot analysis of lysates from treated and mock cells was performed; the blots were probed with primary and secondary antibodies (**A**); Relative band intensity of phospho-p53 or phosphor-p21 was normalized by β actin, compared to the mock cells, and quantified using imageJ based on triplicate replicates of each experiment (**B**); Relative fold levels in treated and mock cells appear as ratio of indicated mRNA/GAPDH mRNA after performing real time PCR assays (**C**). \*\*, *p* value \< 0.01; \*\*\*, *p* value \< 0.001 compared with untreated cells.](molecules-21-00601-g006){#molecules-21-00601-f006}

![Decrease of CK2α/β expression in γ-bisabolene-treated cells. Cells were treated with γ-bisabolene for 48 h, and then harvested for real time PCR (**A**) and western blot assays (**B**,**C**); Relative mRNA levels of CK2α and CK-2β were normalized by GAPDH, and then compared to un-treated cells, respectively. Relative band intensity of CK2α was normalized by β actin, compared to the mock cells, and quantified using image J based on triplicate replicates of each experiment (**C**); GeneGO Meta-Core pathway analysis of the results predicts p53-mediated apoptosis pathway in treated cells (**D**). \*, *p* value \< 0.05; \*\*, *p* value \< 0.01 compared with untreated cells.](molecules-21-00601-g007){#molecules-21-00601-f007}
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